You are here: Home > Institute of Excellence (CPD) > CPD Events > ICCLC 2026

ICCLC 2026

Date: 16/10/2026 (AEDT)

Venue: Crowne Plaza, Hobart, Tasmania, TAS, 7000

Provider: Cornea & Contact Lens Society of Australia

Contact: CorpComm, [E] info@corpcomm.com.au, [P] 02 9431 8676

Activity Outline

On behalf of the Cornea & Contact Lens Society of Australia (CCLSA), we are absolutely thrilled to invite you to our 20th Anniversary International Cornea & Contact Lens Congress (ICCLC) – right here in the heart of Hobart, Tasmania!

Following the incredible success of ICCLC 2024: Enter the Matrix on the Gold Coast, we’re back with another unforgettable experience. ICCLC 2026: The Art of Possibility promises to be a celebration of innovation, collaboration, and community, bringing together passionate professionals in contact lenses and ocular surface health from across Australia and beyond.

Hosting ICCLC 2026 at Crowne Plaza Hobart means placing delegates right at the centre of everything that makes this Congress special. With its sleek, modern design and unbeatable location in the heart of the city, the venue offers seamless access to Hobart’s best dining, shopping, and scenic spots—all just steps away. Inside, delegates will enjoy state-of-the-art conference facilities, warm hospitality, and stunning views of the city and surrounding landscapes. Whether you're networking over coffee, diving into a keynote session, or unwinding after a full day of learning, Crowne Plaza provides the perfect balance of professionalism and relaxation.

We’ve curated a dynamic program filled with cutting-edge research, engaging discussions, and plenty of opportunities to connect, learn, and be inspired. Whether you're an optometrist, ophthalmologist, researcher, or industry leader, ICCLC 2026 is your chance to be part of something truly special.

So pack your curiosity, your passion, and maybe a warm jacket – and get ready for an unforgettable journey in Hobart!

Welcome to ICCLC 2026. Let’s explore the art of what’s possible – together.

Learning Objectives

  • Interpret higher‑order aberration profiles and relate them to visual symptoms and functional vision quality
  • Explain how different contact lens modalities influence HOAs in keratoconus and other irregular corneal conditions
  • Select lens design features and clinical strategies that can reduce HOA‑related visual degradation
  • Apply structured, case‑based reasoning to optimise lens performance and visual outcomes in patients with elevated HOAs
  • Gather and interpret corneal topography
  • Identify when to use spherical versus toric RGP lenses
  • Understand the key characteristics of a well-fitting RGP lens
  • Apply principles of empirical RGP fitting and software-guided lens design
  • Learn how to express meibomian glands with the safest protocol, including lid debridement
  • Learn how to correctly assess and diagnose meibomian glands
  • Learn how to Perform ZEST lid treatment
  • Learn how to safely perform LLLT treatment and what to expect from this treatment
  • Learn how to explore and treat lagophthalmos.
  • Design and assess a scleral lens fit using a Pentacam and OCT 2
  • Apply corrections for HOAs to scleral lenses
  • Discuss types of instrumentation can be used to assess scleral lenses
  • Describe latest research on scleral lenses and associated imaging techniques
  • Be aware of the value of various devices that can improve the ocular surface for contact lens wearers
  • Be aware of pharmaceutical therapies that improve the ocular surface for contact lens wearers
  • Be aware of the ways in which tear supplementation may improve the ocular surface for contact lens wearers
  • Be aware of the ways in which lid hygiene can improve the ocular surface for contact lens wearers.
  • Describe the epidemiology, pathophysiology, and clinical presentation of keratoconus, including key risk factors and genetic considerations
  • Identify and apply appropriate diagnostic techniques for keratoconus, including corneal topography, tomography, and clinical assessment criteria for early and progressive disease
  • Differentiate keratoconus from other corneal ectatic disorders, such as pellucid marginal degeneration and keratoglobus, using clinical and imaging findings
  • Review the latest understanding of light therapies for myopia control
  • Overview the findings of recent studies on atropine concentrations in non-Asian populations
  • Understand the next generation of myopia control spectacle lens designs
  • Describe the latest data on 'boosting' myopia control efficacy in ortho-k, soft contact lenses and spectacles
  •  Understand the risks associated with contemporary contact lens wear
  • Summarise what we know about reducing risk of more severe disease
  • Appreciate why certain microorganisms are more common in contact lens related infections than in non-contact lens-related infections
  • Appreciate emergent questions in corneal infection including in use of myopia control contact lenses, paediatric contact lens use, Acanthamoeba disease and use of coloured or cosmetic contact lenses
  • Distinguish the layers of the cornea viewed under the in vivo confocal microscope
  • To understand how Functional in vivo confocal microscopy can be used to visualise purported corneal immune cells
  • Visualise how purported corneal immune cells interact with corneal nerves
  • Understand if corneal neuroimmune interactions change over the course of a day
  •  Explain the impact of higher-order ocular aberrations in keratoconus and the limitations of conventional spherical scleral lens designs
  • Understand the ray-tracing–based optical modelling for simulating and optimising scleral contact lens designs
  • Evaluate how front surface parameters (radius of curvature and conic asphericity) and lens decentration influence wavefront RMS and overall optical quality
  • Apply evidence-based insights to optimise scleral lens design strategies
  • The increase in risk for the development of microbial keratitis (MK) in non-compliant patients
  • How non-compliance with lens replacement, sleeping in lenses, inappropriate solution and case usage and poor hand-washing increases the risk of both infiltrative keratitis and MK
  • Various methods to reduce potential non-compliance issues in contact lens wearers
  • Understanding the risk factors for bacterial, fungal and acanthamoeba (aka infectious keratitis)
  • Recognise the differentiating clinical features of infectious keratitis
  • Understand the impact of infectious keratitis on patients and the health system
  • Apply strategies to minimise the occurrence of infectious keratitis
  • Discuss clinical features of dry eye disease in women with breast cancer undergoing aromatase inhibitors treatment
  • Describe ocular surface and adnexal adverse events of chemotherapy including onset and recovery times following antibody-drug conjugates (ADCs)
  • Understand guidelines that optometrists and ophthalmologists in practice should be aware of when managing patients on anti-cancer treatments and resources for patient support and education
  • Recognise the clinical features of neurotrophic keratopathy and persistent epithelial defects in practice, and explain how topical insulin eye drops and other emerging therapies work to support corneal healing in patients where standard treatments have failed
  • Identify which patients with non-healing corneal ulcers may be candidates for neurotrophic therapies — including insulin drops, cenegermin (Oxervate), and autologous serum — and know when and how to refer appropriately for specialist care
  • Interpret topographical maps of irregular cornea accurately and understand the importance of the map settings options
  • Determine which Rose K designs are applicable for the type of irregular cornea they are fitting
  • Apply an ordered 5 step fitting system to approach the contact lens fitting
  • Identify the key factors which can maximise the success rate for a contact lens fit
  • Understand the clinical relevance of managing myopia
  • Gain confidence in prescribing the various commercially available myopia treatment options
  • Hands on opportunity to test drive myopia equipment, and hear first-hand tips from experienced clinicians on how to best set up your practice for success
  • Practical approaches to treatment planning, patient communication and how to monitor and followup in practice
  •  Summarise key insights from recent research presented by leading experts in ocular surface and contact lens science
  • Discuss practical clinical applications of emerging evidence through direct interaction with experts. Integrate updated evidence‑based principles into their own contact lens fitting and management strategies. 4. Evaluate and refine their current clinical approaches using expert guidance and contemporary research findings
  •  Recognise when corneal and limbal RGP lenses are appropriate alternatives to scleral lenses in the management of post-graft corneas
  • Understand the RGP options available including standard, reverse geometry, and limbal RGP lenses for post-graft eyes
  • Interpret fluorescein patterns and corneal topography to optimise RGP lens fit and troubleshoot common fitting challenges in grafted corneas
  • Identify the advantages and limitations of non-scleral lens options when managing post-graft conditions
  • Describe the key limitations of current clinical approaches for evaluating tear film health
  • Understand the potential utility of quantifying tear viscoelasticity for dry eye diagnosis.
  • Understand how a scleral lens and the fluid reservoir influence corneal oxygen supply
  • Understand regional variations in scleral lens induced corneal oedema
  • Understand the latest evidence regarding scleral lens fenestrations and corneal oedema
  • Understand how peripheral scleral lens modifications may be used to alter tear exchange
  • Describe the eye health and contact lens portfolio for Bausch and Lomb
  • To review the features and benefits of multifocal contact lenses
  • To highlight the features of Bausch & Lomb's 3-Zone Progressive design
  • To overview the benefits of the Blink eyedrop range
  • Discover how the novel optics in ACUVUE® Abiliti® 1-Day lenses allows for myopia control efficacy without compromising visual acuity, inclusive of 3-year randomised controlled trial data
  • Discover the 3 technologies behind ACUVUE® OASYS MAX 1-Day Multifocal – Pupil Optimised Design, Optiblue light filter(TM) and TearStable(TM) for comfort & and understand how to optimize multifocal success
  • Understand and challenge common myths around multifocal prescribing 
  • Understand the clinical relevance of managing myopia 
  • Gain confidence in prescribing the various commercially available myopia treatment options
  • Discuss practical approaches to treatment planning, patient communication and how to monitor and follow-up in practice
  • Summarise key insights from recent research presented by leading experts in ocular surface and contact lens science
  • Discuss practical clinical applications of emerging evidence through direct interaction with experts
  • Integrate updated evidence‑based principles into their own contact lens fitting and management strategies.
  • Evaluate and refine their current clinical approaches using expert guidance and contemporary research findings
  • Recognise when corneal and limbal RGP lenses are appropriate alternatives to scleral lenses in the management of post-graft corneas
  • Understand the RGP options available including standard, reverse geometry, and limbal RGP lenses for post-graft eyes
  • Interpret fluorescein patterns and corneal topography to optimise RGP lens fit and troubleshoot common fitting challenges in grafted corneas
  • Identify the advantages and limitations of non-scleral lens options when managing post-graft conditions
  •  Describe the key limitations of current clinical approaches for evaluating tear film health
  • Understand the potential utility of quantifying tear viscoelasticity for dry eye diagnosis.
  • Understand how a scleral lens and the fluid reservoir influence corneal oxygen supply
  • Describe regional variations in scleral lens induced corneal oedema.
  • Discuss the latest evidence regarding scleral lens fenestrations and corneal oedema
  • Describe how peripheral scleral lens modifications may be used to alter tear exchange
  • Describe the innovative evolution of contact lens materials
  • Explain contemporary approaches to measuring contact lens performance
  • Evaluate modern contact lens material performance using practitioner experience
  • Evaluate modern contact lens material performance using patient-reported insights 
  • Explain the key challenges and barriers in fitting speciality contact lenses, including complexity, cost, time requirements, and practitioner experience limitations
  • Describe how emerging technologies and AI-driven platforms streamline custom contact lens design and fitting, improving efficiency, accessibility, and clinical outcomes
  •  Apply principles of scleral lens design and fitting, including sagittal depth (SAG), toricity (ΔSAG), landing zone design, and clinical assessment techniques
  • Be aware of potential developments for contact lenses to detect ocular disease
  • Be aware of potential developments for contact lenses to detect systemic disease
  • Be aware of potential developments for contact lenses to treat ocular surface disease via drug delivery materials
  • Be aware of the potential for contact lenses to act as sophisticated imaging devices
  • Identify the key ocular risks associated with high myopia, including common retinal pathologies such as myopic maculopathy, retinal detachment, and peripheral degenerations
  • Recognise clinical features and red flags of syndromic myopia, and differentiate these from non-syndromic high myopia in practice
  • Assess patients with high myopia using appropriate clinical and imaging techniques to support early detection of retinal complications
  • Apply evidence-based myopia control strategies
  • Describe key clinical behaviours and decision‑making patterns used by leading keratoconus contact lens practitioners
  • Explain the scientific rationale underpinning these best‑practice approaches to keratoconus management
  • Apply evidence‑based principles to select and modify lens designs for different keratoconus presentations
  • Integrate practical, clinician‑tested strategies into their own workflow to improve patient outcomes and streamline complex fittings
  • Describe the major classes of immune cells present in the human cornea
  • Discuss the current imaging modalities that enable tracking of individual immune cells in the human eye

Max CPD hours awarded: 21

Session Information

Name
Day 3: CCLSA Brien Holden Memorial Award & Lecture: The Things That Oxygen Can’t Fix
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.75
Duration of CPD Session/Module inclusive of Assessment Component
0.75
Name
Day 2: Kenneth W. Bell Medal Lecture : Corneal Infection – Is it Still Problem in Contact Lens Wear?
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 2: Defining the dynamic interactions between corneal immune cells and nerves
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Lighting a Spark: Beyond Sclerals in Post-Graft Cornea Fitting
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 2: Custom scleral contact lenses for enhanced keratoconus correction
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
ADMiER: A vision for the future of dry eye diagnosis
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Scleral lens tear flO2w
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 1 Bausch + Lomb Lunchtime Session: Go with the most progressive
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1.25
Duration of CPD Session/Module inclusive of Assessment Component
1.25
Name
Day 1 - Workshop 1 Managing Higher Order Aberrations in Practice
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Day 1: Workshop 2 Advanced Corneal RGPs : Tips & Tricks
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Compliance!
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
AK & MK
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 2: Broadening Horizons on the Ocular Surface Complications of Chemotherapy Agents: Tailoring Efficient Care
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Contact Lens Pearls. Innovative Design & Manufacture
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Innovative Anterior Segment Therapies
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
The Future
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Myopia management
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 1: Workshop 3 Advanced Dry Eye: Diagnosis & Management
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Day 1: Workshop 4 Scleral Lenses: Advanced Principles
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Take Home Tips for Keratoconus Management
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
Day 2: workshop 5 Scleral Lenses: Making it Work!
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Day 2 workshop 6 Keratoconus Success
Clinical?
Yes
Interactive?
Yes
Therapeutic?
No
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Johnson and Johnson Breakfast Session: Johnson & Johnson BREAKFAST SESSION: From Paediatrics to Presbyopia : Innovation across a lifetime of vision
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
1
Duration of CPD Session/Module inclusive of Assessment Component
1
Name
Day 3 Myopia & More including Biometry & Equipment
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Day 3: C6 ICCLC Interactive Quiz: TPAs Path Quiz Bingo inflammation, infection AK MK
Clinical?
Yes
Interactive?
Yes
Therapeutic?
Yes
Duration of CPD Session/Module
1.5
Duration of CPD Session/Module inclusive of Assessment Component
1.5
Name
Day 2: The Ocular Surface
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Day 2: Grafts & Cones
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Day 1 : Myopia: A Farsighted View
Clinical?
Yes
Interactive?
No
Therapeutic?
Yes
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Day 2: Immunology & The Anterior Segment
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25
Name
The art of evolving contact lens performance through innovation
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.5
Duration of CPD Session/Module inclusive of Assessment Component
0.5
Name
Panel Q+A
Clinical?
Yes
Interactive?
No
Therapeutic?
No
Duration of CPD Session/Module
0.25
Duration of CPD Session/Module inclusive of Assessment Component
0.25

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.